Healthcare costs: six new measures adopted in Bern

Context

TL;DR

• Six measures adopted on Monday in Bern
• Home care and emergency care among the areas
• The measures are in addition to the 12 from 2025
• Economic impact not yet estimated

Key facts

• Decision → fifth round table on containing healthcare costs
• Location → Bern
• Measures → six
• Implementation → from next year
• Savings, if they work → over 300 million annually
• Participants → the Price Supervisor, the scientific community, patients, the pharmaceutical industry, health insurers, hospitals, doctors and the cantons

According to the source, the fifth round table on containing costs in the healthcare sector adopted six new measures in Bern on Monday. In addition to Federal Councillor Elisabeth Baume-Schneider, the meeting was attended by the Price Supervisor, the scientific community, patients, the pharmaceutical industry, health insurers, hospitals, doctors and the cantons.

Areas covered by the six measures

The package concerns outpatient and home care, the goal of reducing overcrowding in emergency departments, and care programmes for chronically ill patients. The proposals also include greater transparency regarding the costs of medical devices and coordinated medicine supplies in nursing homes.

The six measures add to the 12 decided in 2025 and, according to reports, will be implemented from next year. However, the text does not provide an economic estimate for the new package. Compared with the first, it describes it as more systemic. The content of the six decisions is described by area rather than in a separate fact sheet for each measure.

The available reference remains the first package: if the new measures work, the savings should exceed the 300 million estimated annually at that time. The wording maintains a precise condition: the amount is not presented as an outcome already achieved, nor as a certain forecast for each measure.

Operational details

The comparison with the previous package can be viewed on three levels: quantity, approach and measurement. The first package referred to in the source comprises 12 decisions from 2025; the fifth roundtable adopted six new measures. This is therefore not a figure that, on its own, makes it possible to establish an increase or reduction in costs. The source describes the new measures as more systemic, but does not assign them an economic impact.

The 300-million annual threshold is therefore a conditional reference: the savings would have to exceed it if the new measures work. It is not a figure attributed to individual interventions and does not make it possible to calculate what share would relate to outpatient care, programs for chronically ill patients or the other areas.

From care to coordination

The most concrete connection concerns how the stakeholders should collaborate. The medical societies will draw up a list of therapies to be carried out primarily at home. The insurers can then inform patients about them. Invoices must also include more detailed information about the medical devices used.

This sequence links a professional decision, information for patients and invoice transparency, without quantifying savings for each step. The package also includes coordinated procurement of medicines for nursing homes, but the source does not indicate separate volumes, prices or timelines for this measure. For people living in Switzerland, the verifiable fact is therefore the breadth of the sectors involved; an effect already produced on costs is not documented.

Key points

The indicated timetable remains general: the measures will be implemented from next year, without a more precise date in the text. The economic description also has an explicit limitation. The impact of the six measures has not been estimated, so the reference to 300 million annually cannot be turned into a final accounting, savings already available, or an amount allocated to a canton, a hospital, or a category of patients.

What is documented

The source details two operational steps. Medical societies will prepare a list of therapies to be carried out as a priority at home, and insurers will be able to use it to inform patients. Invoices will have to contain more detailed information on the medical devices used. However, the text does not indicate the number of therapies that will be included in the list, the date of its publication, or the savings associated with these steps.

The text also lacks separate volumes, prices, and timelines for the coordinated procurement of medicines in nursing homes. The comparison with the 12 measures decided in 2025 does not provide a ranking of effectiveness: the source does not indicate which of the six interventions would produce the greatest savings and does not report results already measured for the previous package.

Thus, the content of the decisions and their economic assessment remain separate. The areas of intervention and the collaborative process among medical societies, insurers, and patients are defined; the overall impact has not yet been quantified. To follow the topic of health insurance, consult cassa malati e LAMal.

Source: rsi.ch